Pharmaceuticals

Evernorth to offer Stelara biosimilar at no copayment

bexib
By bexib 0 Min Read

This is the second biosimilar the company is offering to customers at this price point.

You Might Also Like

The future of periodontal disease treatment

Prime Therapeutics and Magellan RX Announce Partnership to Lower Specialty Drug Prices for Plan Providers

Leuko device remotely monitors cancer patients undergoing chemotherapy

Geron’s first recognition after 33 years marks a turning point in Nobel Prize-winning science

Digital Protection: Q&A with Jeffrey Bernstein

Share This Article
Previous Article Florida and Texas home price growth slows as inventory soars
Next Article First barter trade between Russia and China could begin this fall, sources say
Leave a Comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Stay Connected

Latest News

Chart: AI outlook, employee vs. Q1 2025
Retail & E-commerce
10 Made in America Valentine’s Gift Ideal from Etsy
Manufacturing
SUMSUB starts Australian DVS verification of safe ID check
Fintech
Indian cash -free payments secure the $ 53 million US funded by PUBG Publisher Krafton.
Fintech